检验医学 ›› 2019, Vol. 34 ›› Issue (9): 795-799.DOI: 10.3969/j.issn.1673-8640.2019.09.006

• 临床应用研究?论著 • 上一篇    下一篇

上海市某教学医院淋病奈瑟菌耐药特征及耐药机制

王辉, 周爱萍, 吴文娟()   

  1. 同济大学附属东方医院,上海 200123
  • 收稿日期:2018-10-10 出版日期:2019-09-30 发布日期:2019-09-29
  • 作者简介:null

    作者简介:王 辉,男,1980年生,学士,主管技师,主要从事微生物鉴定和耐药机制研究。

  • 基金资助:
    上海市卫生系统优秀人才培养计划(2017BR032);上海市浦东新区卫生系统重点学科项目(PWZxk201709)

Characteristic and mechanism of drug resistance of Neisseria gonorrhoeae in a teaching hospital of Shanghai

WANG Hui, ZHOU Aiping, WU Wenjuan()   

  1. Shanghai East Hospital,Tongji University,Shanghai 200123,China
  • Received:2018-10-10 Online:2019-09-30 Published:2019-09-29

摘要:

目的 了解同济大学附属东方医院南院淋病奈瑟菌(简称淋球菌)的耐药特征、耐药质粒型别和耐药机制,为淋球菌的防控提供参考依据。方法 收集2016年9月—2017年9月同济大学附属东方医院南院142株淋球菌临床分离株,采用纸片扩散法进行淋球菌对7种临床常用抗菌药物的体外药物敏感性试验;采用头孢硝噻吩法检测菌株β-内酰胺酶;对β-内酰胺酶阳性菌株的质粒进行分子分型,分析其流行病学特征;扩增头孢菌素非敏感菌株penA基因并测序,与参考菌株比对,分析不敏感的机制。结果 淋球菌对青霉素、头孢曲松、头孢克肟、四环素、环丙沙星、大观霉素和阿奇霉素的非敏感率分别为100%、1.4%、17.6%、99.3%、99.3%、0%和8.5%。有54株(38%)淋球菌产β-内酰胺酶,其中携带亚洲型、非洲型和多伦多型质粒的淋球菌分别有26株(48%)、27株(50%)和1株(2%)。25株头孢菌素非敏感菌株中,药物作用靶蛋白[青霉素结合蛋白2(PBP2)]均发生了突变。突变点主要集中在311~582氨基酸位点,有12株突变位点较少(≤10个),但存在A501T/V、A516G、G542S、P551S/T关键位点突变;另外13株突变位点较多(50~60个),但无关键突变位点。结论 治疗淋球菌感染经验用药可首选头孢曲松和大观霉素,阿奇霉素和头孢克肟可作为备选药物,青霉素、四环素和环丙沙星已经不适用于淋球菌感染的治疗。淋球菌对β-内酰胺类抗菌药物耐药,以携带非洲型质粒和亚洲型质粒为主,多伦多型质粒少见。淋球菌对头孢菌素不敏感的机制较复杂,药物作用靶蛋白突变多样。

关键词: 淋病奈瑟菌, 耐药, 流行病学特征

Abstract:

Objective To investigate the characteristic,plasmid type and mechanism of drug resistance of Neisseria gonorrhoeae in Tongji University Shanghai East Hospital South Campus,and to provide a reference for the prevention of Neisseria gonorrhoeae. Methods A total of 142 isolates of Neisseria gonorrhoeae from Tongji University Shanghai East Hospital South Campus were collected from September 2016 to September 2017. Drug susceptibility test in vitro of 7 kinds of common antibiotics was performed by disc diffusion method. The β-lactamase was determined by nitrocephin. The plasmids from all β-lactamase-positive isolates were typed and analyzed for epidemic characteristics. Gene penA of non-sensitive isolates to cephalosporin was amplified and sequenced,which were compared with that of reference isolates for analyzing their drug resistance characteristics. Results The non-susceptibility rates to penicillin,ceftriaxone,cefixime,tetracycline,ciprofloxacin,spectinomycin and azithromycin were 100%,1.4%,17.6%,99.3%,99.3%,0% and 8.5%,respectively. Totally,54(38%) isolates produced β-lactamase,and the plasmid types were Asian plasmid(26 isolates,48%),African plasmid(27 isolates,50%) and Toronto/Rio plasmid(1 isolate,2%). Target protein for drug action [penicillin-binding protein 2(PBP2)] in all non-sensitive isolates to cephalosporin were mutated. The mutation points were mainly concentrated in 311-582 amino acid sites. There were 12 isolates with fewer mutation sites(≤10). There existed A501T/V,A516G,G542S and P551S/T key mutations,and the other 13 isolates had more mutation sites(50-60),but there was no above key mutation site. Conclusions Ceftriaxone and spectinomycin are the first experience medication for Neisseria gonorrhoeae therapy,azithromycin and cefixime could be candidates,and penicillin,tetracycline and ciprofloxacin have not been suitable for therapy. For β-lactamase resistance,there are mainly Neisseria gonorrhoeae isolates carrying Asian plasmid and African plasmid in Shanghai. The mechanism of Neisseria gonorrhoeae resistance to cephalosporin is complex,and drug action target protein mutagenesis is various.

Key words: Neisseria gonorrhoeae, Drug resistance, Epidemics

中图分类号: